NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESNIH · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESNIH

Task C13: GMP Manufacturing of Oxfendazole Clinical Trial Material and Stability Study

Mirsalis, Jon (Contact)·SRI International, CA·2018–2025·COMPLETED

Donate

INSTITUTION

SRI International, CA

PRINCIPAL INVESTIGATOR

Mirsalis, Jon (Contact)

FUNDING

$72K

YEAR

2018

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESN01includeplanningtherapeuticstoxinsidentificationtoxicologymanufacturingclinicalfacilitatepreclinicaldevelopmentsafetypromisinginfectiousdiseasecausing

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.